InvestorsHub Logo
Followers 58
Posts 10144
Boards Moderated 1
Alias Born 09/21/2016

Re: bas2020 post# 445862

Thursday, 01/04/2024 10:54:08 AM

Thursday, January 04, 2024 10:54:08 AM

Post# of 462251
If you like/agree w/Dr.M.'s style or methods we must agree the guy has guts. He is going into the opponents kitchen and flipping them the bird w/the plans for next weeks J.P.M. conference. These are the actions of a guy who is committed to the mission , not someone who is standing on the sidelines while others take the risks and heat. IMO, those who have been there, know it when they see it.

IMO, he is doing the right thing. He has BP/WS opponents who wish him boundless (unwell) but he going to take the hill anyways. IMO, the U.S. drug development system is not effective b/c such work cannot be done unless informed risks are taken as appropriate. He presents the spirit of a warrior, Semper fi, dude.]

"NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders today announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference. Anavex’s President and Chief Executive Officer, Christopher U Missling, PhD, is scheduled to present at the conference at the Westin St. Francis in San Francisco, CA on January 11, 2024 at 10:30am Pacific Standard Time (PST)."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News